Health Catalyst (NASDAQ: HCAT) director Nelson submits initial Form 3
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Health Catalyst, Inc. director Steven H. Nelson filed an initial ownership report on Form 3. This filing establishes his status as a director and confirms that, as of this report, there are no buy, sell, or other insider transactions disclosed in the data provided.
Positive
- None.
Negative
- None.
FAQ
What does Steven H. Nelson’s Form 3 filing for HCAT indicate?
The Form 3 filing shows that Steven H. Nelson is a director of Health Catalyst, Inc. It serves as an initial statement of beneficial ownership, and in the data provided it does not report any insider purchases, sales, or other equity transactions.
Does the Health Catalyst (HCAT) Form 3 show any insider buying or selling?
No. The transaction summary in this Form 3 for Health Catalyst, Inc. shows zero buy, sell, exercise, gift, tax withholding, or restructuring transactions. It functions purely as an initial ownership report without recording any trading activity in the company’s securities.
What role does the reporting person hold at Health Catalyst (HCAT)?
The reporting person, Steven H. Nelson, is identified as a director of Health Catalyst, Inc. This role typically involves board-level oversight and governance responsibilities, and the Form 3 formally records his status as an insider subject to SEC reporting requirements.
Why is a Form 3 important for Health Catalyst (HCAT) investors?
Form 3 marks when an individual becomes an SEC-reporting insider at Health Catalyst, Inc. It establishes a baseline for future Forms 4 and 5, which will disclose any subsequent trades or equity awards, improving transparency around director and officer holdings in the stock.
Does the Form 3 for HCAT include any derivative securities details?
No derivative positions are shown in the data for this Form 3. The derivative summary is empty, and the transaction summary indicates no derivative exercises or related transactions, so only the insider’s status as a director is clearly established here.